Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

High serum substance P levels and mortality after malignant middle cerebral artery infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

J Crit Care. 2020 Jan 20;57:1-4. doi: 10.1016/j.jcrc.2020.01.022. [Epub ahead of print]

PMID:
31991332
2.

Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients.

Lorente L, Martín MM, Abreu-González P, Ramos L, Cáceres JJ, Argueso M, Solé-Violán J, Jiménez A, García-Marín V.

BMC Res Notes. 2019 Dec 3;12(1):789. doi: 10.1186/s13104-019-4828-5.

3.

Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Nov 28;9(12). pii: E346. doi: 10.3390/brainsci9120346.

4.

High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A.

World Neurosurg. 2020 Feb;134:e476-e480. doi: 10.1016/j.wneu.2019.10.106. Epub 2019 Oct 25.

PMID:
31669537
5.

High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 10;9(10). pii: E269. doi: 10.3390/brainsci9100269.

6.

Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurol. 2019 Oct 17;19(1):238. doi: 10.1186/s12883-019-1479-z.

7.

High Serum DNA and RNA Oxidative Damage in Non-surviving Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Oct 9. doi: 10.1007/s12028-019-00864-8. [Epub ahead of print]

PMID:
31598840
8.

The Serum Melatonin Levels and Mortality of Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Abreu-González P, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 1;9(10). pii: E263. doi: 10.3390/brainsci9100263.

9.

High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

Lorente L, Martín MM, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Dec;132:e630-e636. doi: 10.1016/j.wneu.2019.08.060. Epub 2019 Aug 21.

PMID:
31442656
10.

Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

World Neurosurg. 2019 Dec;132:e613-e617. doi: 10.1016/j.wneu.2019.08.064. Epub 2019 Aug 20.

PMID:
31442647
11.

Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Aug 5. doi: 10.1007/s12028-019-00800-w. [Epub ahead of print]

PMID:
31385181
12.

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, González-Rivero AF, Orbe J, Rodríguez JA, Páramo JA.

BMC Neurol. 2019 Jul 18;19(1):167. doi: 10.1186/s12883-019-1401-8.

13.

Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Dec;31(3):486-493. doi: 10.1007/s12028-019-00739-y.

PMID:
31115825
14.

Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.

Lorente L, Martín MM, González-Rivero AF, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Jun;126:e1537-e1541. doi: 10.1016/j.wneu.2019.03.179. Epub 2019 Mar 27.

PMID:
30926559
15.

Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, González-Rivero AF, Orbe J, Rodríguez JA, Páramo JA.

J Crit Care. 2019 Jun;51:117-121. doi: 10.1016/j.jcrc.2019.02.014. Epub 2019 Feb 19.

PMID:
30802757
16.

Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Lorente L, Martín MM, Abreu-González P, Pérez-Cejas A, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

J Int Med Res. 2018 Aug;46(8):3268-3277. doi: 10.1177/0300060518775008. Epub 2018 May 30.

17.

Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage.

Lorente L, Martín MM, Pérez-Cejas A, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurosci. 2018 Apr 16;19(1):23. doi: 10.1186/s12868-018-0424-1.

18.

High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.

Lorente L, Martín MM, Pérez-Cejas A, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurol. 2018 Mar 24;18(1):32. doi: 10.1186/s12883-018-1038-z.

19.

Serum Malondialdehyde Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Riaño-Ruiz M, Jiménez A, García-Marín V.

World Neurosurg. 2018 May;113:e542-e547. doi: 10.1016/j.wneu.2018.02.085. Epub 2018 Feb 23.

PMID:
29477698
20.

Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury.

Lorente L, Martín MM, Abreu-González P, Pérez-Cejas A, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurol. 2017 Jul 19;17(1):138. doi: 10.1186/s12883-017-0922-2.

Supplemental Content

Loading ...
Support Center